Achalasia is a motility failure of the esophagus. Pathogenetically it
is based on the destruction of mainly inhibitory neurons in the myente
ric plexus of the tubular and sphincteric part of the esophagus. To di
stinguish the primary achalasia from secondary manifestations, mainly
in malignomas, is of differential-diagnostical interest. For therapy t
he proved methods of pneumatic dilatation and esophagomyotomy are avai
lable. Starting from this therapeutic spectrum and the more recent cur
ative method of intrasphincteric injection of botulismotoxin optimized
therapeutic strategies for the achalasia-patient will have to be work
ed out.